Description
Isryl-M1 Tablet SR
Category: Anti-diabetic combination drug
Composition: Glimepiride + Metformin
Uses
Treats Type 2 Diabetes Mellitus in adults by controlling blood sugar levels.
Key Benefits
Dual Action:
Glimepiride stimulates insulin release from the pancreas.
Metformin reduces liver glucose production and improves insulin sensitivity.
Lowers risk of diabetes complications (kidney damage, nerve problems, etc.).
Dosage & Administration
Form: Sustained-release tablet (do not crush/chew).
When to take: With food, at the same time daily.
Missed dose: Take ASAP, but skip if close to next dose. Never double dose.
Side Effects
Common: Hypoglycemia (sweating, dizziness, headache), nausea, diarrhea, stomach pain.
Serious (Rare): Lactic acidosis (metformin-related; symptoms: muscle pain, breathing difficulty).
Safety Warnings
Avoid Alcohol: Increases hypoglycemia & lactic acidosis risk.
Contraindications:
Type 1 diabetes, diabetic ketoacidosis.
Severe kidney/liver disease.
Special Precautions:
Pregnancy/Breastfeeding: Unsafe – consult doctor.
Kidney/Liver Impairment: Dose adjustment needed; avoid in severe cases.
Driving: Caution due to hypoglycemia risk.
Lifestyle Tips
Monitor blood sugar regularly.
Follow a healthy diet, exercise, and weight management plan.
Carry fast-acting glucose (juice, candy) to manage hypoglycemia.
Why Continue Medication?
Stopping suddenly can spike blood sugar, increasing complications risk.
Note: Always consult your doctor for personalized advice and dose adjustments. This is not a substitute for professional medical guidance.







Reviews
There are no reviews yet.